Ischemia Cardio-Cerebrovascular Disease
Conditions
Interventions
Group A(Drug Group):Conventional antithrombotic western medicine combined with Tian Xin Tai Xueshuanxinmaining tablets
Group B (Control Group):Conventional antithrombotic western medicine combined with placebo
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: (The following 4 items are required to comply with): (1) Comply with the diagnosis of western medicine cerebral infarction; (2) NIHSS score 3 to 10 points; (3) Aged 35 to 75 years; (4) The patient or their legal guardians signed the informed consent.
Exclusion criteria
Exclusion criteria: (Subjects would be exclusive when complied any of the item following) (1) Transient ischemic attack (TIA); (2) Cerebral hemorrhage or subarachnoid hemorrhage; (3) Check confirmed that the stroke was caused by brain tumors,brain trauma and blood diseases; (4) Cerebral embolism caused by atrial fibrillation with rheumatic heart disease, coronary hear t disease or any other heart diseases; (5) Bone and joint diseases and some other serious diseases which were associated with liver, kidney, hematopoietic system and endocrine system etc.; (6) Mental disorders or severe dementia; (7) Patients can not be performed with MRI which has accepted pacemaker surgery, coronary intervention surgery or coronary artery bypass surgery; (8) Patients can not be performed with MRI which has a magnetic implant inside.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stroke Specific Quality of Life Scale(SS-QOL); | — |
Secondary
| Measure | Time frame |
|---|---|
| NIH Stroke Scale(NIHSS);Barthel index;Modified Rankin Scale;Mini-Mental State Examination(MMSE);Montreal cognitive assessment(MoCA);Pittsburgh Sleep Quality Index(PSQI);Blood fat testing(CHO, TG, LDL, HDL); | — |
Countries
China
Contacts
Public ContactZHANG Zhan-Jun
Outcome results
None listed